- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/20 - Interferons
Patent holdings for IPC class C12N 15/20
Total number of patents in this class: 35
10-year publication summary
1
|
2
|
0
|
3
|
2
|
0
|
4
|
3
|
1
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Institute of Biophysics, Chinese Academy of Sciences | 108 |
2 |
Novagen Holding Corporation | 27 |
2 |
Hudson Institute of Medical Research | 49 |
2 |
Amgen Inc. | 3779 |
1 |
Novozymes A/S | 3314 |
1 |
Purdue Research Foundation | 3277 |
1 |
Aeras Global TB Vaccine Foundation | 25 |
1 |
Amarillo Biosciences, Inc. | 6 |
1 |
AOBiome LLC | 68 |
1 |
Biogen MA Inc. | 926 |
1 |
Commonwealth Scientific and Industrial Research Organisation | 1652 |
1 |
Fudan University | 585 |
1 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 829 |
1 |
ImmunGene Inc. | 12 |
1 |
Juridical Foundation, Japanese Foundation for Cancer Research | 2 |
1 |
Mat Malta Advanced Technologies Limited | 11 |
1 |
Metabolic Explorer | 200 |
1 |
National University of Singapore | 2228 |
1 |
Peking University | 1111 |
1 |
Pfenex Inc. | 26 |
1 |
Other owners | 12 |